Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors
This document includes guidance for companies (applicants) who wish to put forward submissions/applications to request a switch of an ingredient from prescription to non-prescription status.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records